Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant
The experimental vaccine for bovine malignant catarrhal fever consists of viable attenuated alcelaphine herpesvirus 1 (AlHV-1) derived by extensive culture passage, combined with an oil-in-water adjuvant, delivered intramuscularly. This immunisation strategy was over 80% effective in previous experi...
Main Authors: | George C. Russell, David M. Haig, Mark P. Dagleish, Helen Todd, Ann Percival, Dawn M. Grant, Jackie Thomson, Anna E. Karagianni, Julio Benavides |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136221000073 |
Similar Items
-
Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever
by: Cristina W. Cunha, et al.
Published: (2016-08-01) -
Malignant catarrhal fever (Coryza gangraenosa bovum)
by: Spasojević Filip, et al.
Published: (2008-01-01) -
Ovine Herpesvirus 2 Infection in Foal, Brazil
by: Érica A. Costa, et al.
Published: (2009-05-01) -
Transmission of Ovine Herpesvirus 2 from Asymptomatic Boars to Sows
by: Érica Azevedo Costa, et al.
Published: (2010-12-01) -
Identification and characterisation of Gamma-herpesviruses in zoo artiodactyla
by: Laura Bianchessi, et al.
Published: (2024-02-01)